Electrocardiographic and echocardiographic findings in muscular dystrophy patients with heart failure

被引:1
|
作者
Ogiso, Masataka [1 ]
Isogai, Toshiaki [1 ]
Kato, Ken [1 ]
Tanaka, Hiroyuki [1 ]
Tejima, Tamotsu [1 ]
Isozaki, Eiji [2 ]
机构
[1] Tokyo Metropolitan Tama Med Ctr, Dept Cardiol, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan
[2] Tokyo Metropolitan Neurol Hosp, Dept Neurol, 2-6-1 Musashidai, Fuchu, Tokyo 1830042, Japan
关键词
Muscular dystrophy; Heart failure; Electrocardiography; Echocardiography; CONVERTING ENZYME-INHIBITORS; QRS DURATION; DILATED CARDIOMYOPATHY; BETA-BLOCKERS; JCS; 2011; GUIDELINES; STRATEGY; IMPACT;
D O I
10.1007/s00380-018-1186-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac involvement in muscular dystrophy (MD) is known to cause heart failure (HF). However, little is known about the differences in electrocardiographic and echocardiographic findings between MD patients with and without the experience of hospitalization for HF. We retrospectively identified 95 MD patients (mean age at diagnosis of MD 41.1 +/- 18.7years; males 64.2%), including nine (9.4%) patients who were hospitalized for HF (the HF group) and 86 (90.6%) patients who were not (the non-HF group) during the follow-up period (16.7 +/- 12.2years). The HF group had a significantly wider QRS duration (126.0 +/- 37.6 vs. 98.1 +/- 16.7ms, p<0.001) and QTc interval (454.6 +/- 50.5 vs. 409.5 +/- 23.6ms, p<0.001) at the time of HF hospitalization than the non-HF group. The HF group also had a significantly lower left ventricular (LV) ejection fraction (35.4 +/- 19.2 vs. 62.5 +/- 11.3%, p<0.001) and significantly larger diastolic LV dimension (64 +/- 2 vs. 45 +/- 1mm, p<0.001) and left atrial diameter (38 +/- 12 vs. 29 +/- 6mm, p=0.003) at the time of HF hospitalization than the non-HF group. In the HF group, the QRS duration was significantly wider at the time of HF hospitalization than at the initial electrocardiogram before the development of HF (129.8 +/- 30.7 vs. 119.0 +/- 33.3ms, p=0.018). This study suggests that HF occurs in MD patients with electrocardiographic and echocardiographic abnormalities. Early recognition of abnormal findings during a regular electrocardiographic or echocardiographic follow-up may be useful for identifying cardiac involvement in MD.
引用
收藏
页码:1576 / 1583
页数:8
相关论文
共 50 条
  • [21] Physical Examination and Electrocardiographic Findings in Young Subjects - Are They Predictive of Echocardiographic Findings?
    Grossman, Alon
    Prokupetz, Alex
    Levy, Yuval
    CARDIOLOGY, 2011, 119 (03) : 151 - 154
  • [22] Electrocardiographic and Echocardiographic Findings in Black Athletes: A General Review
    Pambo, Prince
    Scharhag, Juergen
    CLINICAL JOURNAL OF SPORT MEDICINE, 2021, 31 (03): : 321 - 329
  • [23] Echocardiographic and electrocardiographic findings in COVID-19 patients: a cross-sectional study
    Faeze Keihanian
    Hoorak Poorzand
    Amin Saeidinia
    Ali Eshraghi
    The International Journal of Cardiovascular Imaging, 2022, 38 : 2167 - 2175
  • [24] Echocardiographic and electrocardiographic findings in COVID-19 patients: a cross-sectional study
    Keihanian, Faeze
    Poorzand, Hoorak
    Saeidinia, Amin
    Eshraghi, Ali
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2022, 38 (10) : 2167 - 2175
  • [25] Electrocardiographic and Echocardiographic Findings in Asphyxiated Neonates
    Yellanthoor, Ramesh Bhat
    Dineshkumar, R.
    IRANIAN HEART JOURNAL, 2021, 22 (02): : 51 - 57
  • [26] Which place for ivabradine in Duchenne muscular dystrophy with heart failure?
    Fayssoil, Abdallah
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 768 - 769
  • [27] Electrocardiographic features of children with Duchenne muscular dystrophy
    Tang, Liting
    Shao, Shuran
    Wang, Chuan
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [28] AN ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH IDIOPATHIC HEART-FAILURE
    ANDERSSON, B
    CAIDAHL, K
    WAAGSTEIN, F
    CHEST, 1995, 107 (03) : 680 - 689
  • [29] Echocardiographic assessment of patients with heart failure: a practical checklist
    De Sutter, Johan
    Herbots, Lieven
    Lancellotti, Patrizio
    ACTA CARDIOLOGICA, 2008, 63 (06) : 783 - 789
  • [30] Use of advanced heart failure therapies in Duchenne muscular dystrophy
    Wittlieb-Weber, Carol A.
    Villa, Chet R.
    Conway, Jennifer
    Bock, Matthew J.
    Gambetta, Katheryn E.
    Johnson, Jonathan N.
    Lal, Ashwin K.
    Schumacher, Kurt R.
    Law, Sabrina P.
    Deshpande, Shriprasad R.
    West, Shawn C.
    Friedland-Little, Joshua M.
    Lytrivi, Irene D.
    McCulloch, Michael A.
    Butts, Ryan J.
    Weber, David R.
    Knecht, Kenneth R.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2019, 53 : 11 - 14